Search Within

David Norman Brown

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (16)
  2. Meeting Abstract (12)
Groups
  1. Department of Medicine (28)
  2. GSK Faculty (28)
  3. Human Oncology and Pathogenesis Program (28)
  4. Sloan Kettering Institute Postdocs (28)
  5. Solid Tumor Oncology Division (28)
  6. Department of Pathology and Laboratory Medicine (25)

More Groups

People
  1. Jorge Reis-Filho (25)
  2. Sarat Chandarlapaty (18)
  3. Pier Selenica (16)
  4. Britta Weigelt (15)
  5. Fresia Pareja Zea (14)
  6. Pedram Razavi (14)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (7)
  4. 2022 (3)
  5. 2021 (2)
  6. 2020 (7)

More Years

Publications
  1. Cancer Research (6)
  2. Annals of Oncology (4)
  3. Laboratory Investigation (3)
  4. Cancer Cell (2)
  5. Clinical Cancer Research (2)
  6. Journal of Clinical Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. Nature Publishing Group (7)
  3. Oxford University Press (4)
  4. American Society of Clinical Oncology (2)
  5. Cell Press (2)
  6. Nature Research (2)

More Publishers

Results (28)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The genomic landscape of metastatic special histologic types of breast cancer
    Meeting Abstract

    Pareja, F.; Lee, S. S. K.; Beca, F.; Ferrando, L.; Selenica, P.; Brown, D. N.; Wen, H. Y.; Zhang, H.; Brogi, E.; Razavi, P.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic profiling of primary and metastatic breast cancer in men
    Meeting Abstract

    Drago, J. Z.; Serna-Tamayo, C.; Dos Anjos, C. H.; Brown, D. N.; Modi, S.; Jhaveri, K.; Solit, D. B.; Traina, T. A.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
    Journal Article

    Razavi, P.; Li, B. T.; Brown, D. N.; Jung, B.; Hubbell, E.; Shen, R.; Abida, W.; Juluru, K.; De Bruijn, I.; Hou, C.; more...
    Nature Medicine (2019)

    Fulltext@MSK | Save
  • Molecular profiling of ER plus metastatic breast cancers to reveal association of genomic alterations with acquired resistance to CDK4/6 inhibitors
    Meeting Abstract

    Razavi, P.; dos Anjos, C. H.; Brown, D. N.; Qing, L.; Ping, C.; Herbert, J.; Colon, J.; Liu, D.; Mao, M.; Norton, L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Genomic profiling of metastatic breast cancer identifies the Hippo pathway to be a key determinant of CDK4/6 inhibitor sensitivity
    Meeting Abstract

    Razavi, P.; Li, Q.; Li, Z.; Brown, D. N.; Ping, C.; Shen, R.; Sanchez-Vega, F.; Schultz, N. D.; Baselga, J.; Scaltriti, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Massively parallel sequencing analysis of benign melanocytic naevi
    Journal Article

    Lozada, J. R.; Geyer, F. C.; Selenica, P.; Brown, D.; Alemar, B.; Merghoub, T.; Berger, M. F.; Busam, K. J.; Halpern, A. C.; Weigelt, B.; more...
    Histopathology (2019)

    Fulltext@MSK | Save
  • Ultra-deep next-generation sequencing of plasma cell-free DNA in patients with advanced lung cancers: Results from the Actionable Genome Consortium
    Journal Article

    Li, B. T.; Janku, F.; Jung, B.; Hou, C.; Madwani, K.; Alden, R.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Isbell, J. M.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the Hippo pathway
    Journal Article

    Li, Z.; Razavi, P.; Li, Q.; Toy, W.; Liu, B.; Ping, C.; Hsieh, W.; Sanchez-Vega, F.; Brown, D. N.; Da Cruz Paula, A. F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save